QuidelOrtho To Participate In Upcoming Investor Conferences

Core Insights - QuidelOrtho Corporation, a leader in in vitro diagnostics, will participate in two upcoming investor conferences, enhancing its engagement with the investment community [1][5]. Company Overview - QuidelOrtho Corporation specializes in various diagnostic solutions, including clinical chemistry, immunoassay, immunohematology, and molecular testing, aimed at improving patient outcomes [3]. - The company is committed to advancing diagnostics to support a healthier future, reflecting its dedication to innovation and collaboration with healthcare providers [2][3]. Upcoming Events - Management will participate in the Evercore ISI 8th Annual Healthcare Conference on December 2, 2025, at 10:00 a.m. ET [5]. - Additionally, they will engage in the Citi Global Healthcare Conference on December 3, 2025, at 1:00 p.m. ET [5].